EP1456360B1
(de)
*
|
2001-04-19 |
2015-06-03 |
The Scripps Research Institute |
Verfahren und zusammensetzungen zur herstellung von orthoganalen trna/aminoacyl-trna-synthetase-paaren
|
SG160203A1
(en)
*
|
2002-10-16 |
2010-04-29 |
Scripps Research Inst |
Glycoprotein synthesis
|
CN103215228A
(zh)
|
2003-04-17 |
2013-07-24 |
斯克利普斯研究院 |
扩展真核生物遗传密码
|
EP2392923B1
(de)
|
2003-06-18 |
2014-05-21 |
The Scripps Research Institute |
Methode zur Herstellung von Proteinen mit unnatürlichen Aminosäuren
|
US7638297B2
(en)
*
|
2003-07-07 |
2009-12-29 |
The Scripps Research Institute |
Compositions of orthogonal lysyl-tRNA and aminoacyl-tRNA synthetase pairs and uses thereof
|
CA2541166A1
(en)
|
2003-10-14 |
2005-04-28 |
The Scripps Research Institute |
Site-specific incorporation of redox active amino acids into proteins
|
US8778880B2
(en)
|
2004-02-02 |
2014-07-15 |
Ambrx, Inc. |
Human growth hormone modified at position 35
|
JP2008500050A
(ja)
*
|
2004-05-25 |
2008-01-10 |
ザ スクリップス リサーチ インスティテュート |
結晶構造決定のための重原子含有非天然アミノ酸の部位特異的蛋白質組込み
|
NZ582684A
(en)
|
2004-06-18 |
2011-05-27 |
Ambrx Inc |
Use of an antibody or binding fragment thereof comprising a non naturally encoded amino acid coupled to a linker
|
ES2519444T3
(es)
|
2004-09-21 |
2014-11-07 |
The Scripps Research Institute |
Incorporación in vivo de alquinil aminoácidos a proteínas en eubacterias
|
EP1794312A4
(de)
*
|
2004-09-22 |
2009-08-12 |
Scripps Research Inst |
Ortsspezifische etikettierung von proteinen für nmr-studien
|
JP2008516637A
(ja)
|
2004-10-20 |
2008-05-22 |
ザ スクリップス リサーチ インスティテュート |
真正細菌へのn−アセチルガラクトサミンアミノ酸のインビボ部位特異的組込み
|
CA2583735A1
(en)
|
2004-10-27 |
2006-10-19 |
The Scripps Research Institute |
Orthogonal translation components for the in vivo incorporation of unnatural amino acids
|
KR101224781B1
(ko)
|
2004-12-22 |
2013-01-21 |
암브룩스, 인코포레이티드 |
비천연적으로 코딩된 아미노산을 포함하는 인간 성장호르몬의 조제물
|
CN101087875B
(zh)
|
2004-12-22 |
2012-08-22 |
Ambrx公司 |
氨酰基-tRNA合成酶的组合物及其用途
|
CA2590462C
(en)
|
2004-12-22 |
2017-02-28 |
Ambrx, Inc. |
Methods for expression and purification of recombinant human growth hormone
|
US7939496B2
(en)
|
2004-12-22 |
2011-05-10 |
Ambrx, Inc. |
Modified human growth horomone polypeptides and their uses
|
CN103030690A
(zh)
|
2005-06-03 |
2013-04-10 |
Ambrx公司 |
经改良人类干扰素分子和其用途
|
AU2006304110B2
(en)
|
2005-10-12 |
2012-02-02 |
The Scripps Research Institute |
Selective posttranslational modification of phage-displayed polypeptides
|
CA2626522A1
(en)
|
2005-11-16 |
2007-05-24 |
Ambrx, Inc. |
Methods and compositions comprising non-natural amino acids
|
US8921086B2
(en)
|
2005-12-22 |
2014-12-30 |
Pacific Biosciences Of California, Inc. |
Polymerases for nucleotide analogue incorporation
|
US8198044B2
(en)
*
|
2006-03-09 |
2012-06-12 |
The Scripps Research Institute |
Systems for the expression of orthogonal translation components eubacterial host cells
|
EP1994165B1
(de)
|
2006-03-16 |
2014-11-05 |
The Scripps Research Institute |
Genetisch programmierte Expression von Proteinen, die die nicht natürliche Aminosäure Phenylselenocystein enthalten
|
US7807411B2
(en)
*
|
2006-05-23 |
2010-10-05 |
The Scripps Research Institute |
Genetically encoded fluorescent coumarin amino acids
|
CN104193815A
(zh)
|
2006-09-08 |
2014-12-10 |
Ambrx公司 |
经修饰的人类血浆多肽或Fc骨架和其用途
|
KR20090052360A
(ko)
|
2006-09-08 |
2009-05-25 |
암브룩스, 인코포레이티드 |
척추동물 세포에서의 서프레서 tRNA 전사
|
BRPI0716963A2
(pt)
|
2006-09-21 |
2013-11-05 |
Scripps Research Inst |
Expressão geneticamente programada de proteínas seletivamente sulfatadas em eubactéria
|
RU2009112104A
(ru)
|
2006-10-18 |
2010-11-27 |
Зе Скрипс Ресеч Инститьют (Us) |
Генетическое встраивание не встречающихся в природе аминокислот в белки клеток млекопитающих
|
ES2385114T3
(es)
|
2007-03-30 |
2012-07-18 |
Ambrx, Inc. |
Polipéptidos de FGF-21 modificados y sus usos
|
AU2008247815B2
(en)
|
2007-05-02 |
2012-09-06 |
Ambrx, Inc. |
Modified interferon beta polypeptides and their uses
|
MX2010004464A
(es)
*
|
2007-10-25 |
2010-06-07 |
Scripps Research Inst |
Incorporacion genetica de 3-aminotirosina a reductasas.
|
WO2009059056A2
(en)
*
|
2007-11-02 |
2009-05-07 |
The Scripps Research Institute |
A genetically encoded boronate amino acid
|
CN101878303B
(zh)
|
2007-11-02 |
2014-04-30 |
斯克利普斯研究院 |
使用包含非天然氨基酸的蛋白质进行定向进化
|
KR101656107B1
(ko)
|
2007-11-20 |
2016-09-08 |
암브룩스, 인코포레이티드 |
변형된 인슐린 폴리펩티드 및 이의 용도
|
EP2889370A1
(de)
|
2007-12-11 |
2015-07-01 |
The Scripps Research Institute |
Unnatürliche In-vivo-Aminosäure-Expression bei der Methylotrophen-Hefe Pichia pastoris
|
MX2010008632A
(es)
|
2008-02-08 |
2010-08-30 |
Ambrx Inc |
Leptina-polipeptidos modificados y sus usos.
|
KR20100125290A
(ko)
*
|
2008-02-08 |
2010-11-30 |
더 스크립스 리서치 인스티튜트 |
유전적으로 코딩된 비천연 아미노산에 의한 면역 내성의 파괴
|
US20110076718A1
(en)
*
|
2008-02-27 |
2011-03-31 |
The Scripps Research Institute |
In vivo incorporation of an unnatural amino acid comprising a 1,2-aminothiol group
|
EP2942404B1
(de)
|
2008-03-31 |
2016-11-23 |
Pacific Biosciences of California, Inc. |
Erzeugung modifizierter polymerasen für erhöhte genauigkeit bei einzelmolekülsequenzierungen
|
ES2654387T3
(es)
|
2008-07-23 |
2018-02-13 |
Ambrx, Inc. |
Polipéptidos G-CSF bovinos modificados y sus usos
|
JP5694171B2
(ja)
|
2008-09-26 |
2015-04-01 |
アンブルックス, インコーポレイテッドAmbrx, Inc. |
修飾されている動物のエリスロポエチンポリペプチドおよびそれらの使用
|
EP2337846B1
(de)
|
2008-09-26 |
2018-01-17 |
Ambrx, Inc. |
Nicht-natürliche aminosäurenreplikationsabhängige mikroorganismen und impfstoffe
|
US20090197339A1
(en)
*
|
2008-12-10 |
2009-08-06 |
The Scripps Research Institute |
In vivo unnatural amino acid expression in the methylotrophic yeast pichia pastoris
|
US8637306B2
(en)
*
|
2008-12-10 |
2014-01-28 |
The Scripps Research Institute |
Production of carrier-peptide conjugates using chemically reactive unnatural amino acids
|
MX349301B
(es)
|
2009-12-21 |
2017-07-21 |
Ambrx Inc |
Polipéptidos de somatotropina bovina modificados y sus usos.
|
MX2012006980A
(es)
|
2009-12-21 |
2012-07-17 |
Ambrx Inc |
Polipeptidos de somatotropina porcina modificados y sus usos.
|
JP6066900B2
(ja)
|
2010-04-26 |
2017-01-25 |
エータイアー ファーマ, インコーポレイテッド |
システイニルtRNA合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
|
AU2011248614B2
(en)
|
2010-04-27 |
2017-02-16 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl tRNA synthetases
|
CN103096910A
(zh)
|
2010-04-27 |
2013-05-08 |
Atyr医药公司 |
与苏氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
CN103097524B
(zh)
|
2010-04-28 |
2016-08-03 |
Atyr医药公司 |
与丙氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
US9034320B2
(en)
|
2010-04-29 |
2015-05-19 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Valyl-tRNA synthetases
|
AU2011248490B2
(en)
|
2010-04-29 |
2016-11-10 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Asparaginyl tRNA synthetases
|
CN103140233B
(zh)
|
2010-05-03 |
2017-04-05 |
Atyr 医药公司 |
与甲硫氨酰‑tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的发现
|
JP6008840B2
(ja)
|
2010-05-03 |
2016-10-19 |
エータイアー ファーマ, インコーポレイテッド |
フェニルアラニルαtRNA合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
|
US8946157B2
(en)
|
2010-05-03 |
2015-02-03 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of seryl-tRNA synthetases
|
WO2011139986A2
(en)
|
2010-05-03 |
2011-11-10 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-trna synthetases
|
CN103096909A
(zh)
|
2010-05-04 |
2013-05-08 |
Atyr医药公司 |
与谷氨酰-脯氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
AU2011248101B2
(en)
|
2010-05-04 |
2016-10-20 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-tRNA synthetase complex
|
EP2568996B1
(de)
|
2010-05-14 |
2017-10-04 |
aTyr Pharma, Inc. |
Therapeutische, diagnostische und antikörperhaltige zusammensetzungen im zusammenhang mit proteinfragmenten von phenylalanyl-beta-trna-synthetasen
|
JP6027965B2
(ja)
|
2010-05-17 |
2016-11-16 |
エータイアー ファーマ, インコーポレイテッド |
ロイシルtRNA合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
|
EP2575856B1
(de)
|
2010-05-27 |
2017-08-16 |
aTyr Pharma, Inc. |
Therapeutische, diagnostische und antikörperhaltige zusammensetzungen in zusammenhang mit proteinfragmenten von glutaminyl-trna-synthetasen
|
EP2575857B1
(de)
|
2010-06-01 |
2018-01-24 |
aTyr Pharma, Inc. |
Innovative erkennung therapeutischer, diagnostischer und antikörperhaltiger zusammensetzungen in zusammenhang mit proteinfragmenten von lysyl-trna-synthetasen
|
WO2012009289A2
(en)
|
2010-07-12 |
2012-01-19 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-trna synthetases
|
US8999321B2
(en)
|
2010-07-12 |
2015-04-07 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases
|
AU2011289831C1
(en)
|
2010-07-12 |
2017-06-15 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases
|
KR20130102534A
(ko)
|
2010-07-12 |
2013-09-17 |
에이티와이알 파마, 인코포레이티드 |
히스티딜trna 합성효소의 단백질 단편에 관련된 치료적, 진단적, 및 항체 조성물의 혁신적 발견
|
US8735539B2
(en)
|
2010-08-17 |
2014-05-27 |
Ambrx, Inc. |
Relaxin polypeptides comprising non-naturally encoded amino acids
|
US9567386B2
(en)
|
2010-08-17 |
2017-02-14 |
Ambrx, Inc. |
Therapeutic uses of modified relaxin polypeptides
|
EP2608801B1
(de)
|
2010-08-25 |
2019-08-21 |
aTyr Pharma, Inc. |
Innovative erkennung therapeutischer, diagnostischer und antikörperhaltiger zusammensetzungen in zusammenhang mit proteinfragmenten von tyrosyl-trna-synthetasen
|
TWI480288B
(zh)
|
2010-09-23 |
2015-04-11 |
Lilly Co Eli |
牛顆粒細胞群落刺激因子及其變體之調配物
|
ES2645019T3
(es)
|
2010-10-06 |
2017-12-01 |
Atyr Pharma, Inc. |
Descubrimiento innovador de composiciones terapéuticas, de diagnóstico y de anticuerpos relacionadas con fragmentos de proteínas de triptofanil-ARNt sintetasas
|
US20130078671A1
(en)
*
|
2011-03-25 |
2013-03-28 |
The Texas A&M University System |
Incorporation of two different noncanonical amino acids into a single protein
|
JP6261500B2
(ja)
|
2011-07-22 |
2018-01-17 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
ヌクレアーゼ切断特異性の評価および改善
|
WO2013022982A2
(en)
|
2011-08-09 |
2013-02-14 |
Atyr Pharma, Inc. |
Pegylated tyrosyl-trna synthetase polypeptides
|
US9816084B2
(en)
|
2011-12-06 |
2017-11-14 |
Atyr Pharma, Inc. |
Aspartyl-tRNA synthetases
|
US9822353B2
(en)
|
2011-12-06 |
2017-11-21 |
Atyr Pharma, Inc. |
PEGylated aspartyl-tRNA synthetase polypeptides
|
CN102517241B
(zh)
*
|
2011-12-19 |
2013-06-19 |
中国药科大学 |
一种含有d型氨基酸的双羰基还原酶的突变体的制备方法
|
AU2012368189B2
(en)
|
2011-12-29 |
2017-08-31 |
Atyr Pharma, Inc. |
Aspartyl-tRNA synthetase-Fc conjugates
|
CN104718285A
(zh)
*
|
2012-05-18 |
2015-06-17 |
医药研究委员会 |
利用编码包含BCN基团的氨基酸的正交密码子和正交PylRS合成酶将包含BCN基团的氨基酸整合到多肽中的方法
|
UY35368A
(es)
|
2013-03-08 |
2014-10-31 |
Irm Llc |
Péptidos y composiciones para el tratamiento de daño articular
|
EP2970921B1
(de)
|
2013-03-15 |
2018-09-19 |
aTyr Pharma, Inc. |
Histidyl-trna-synthetase-fc-konjugate
|
CN104099360A
(zh)
*
|
2013-04-12 |
2014-10-15 |
北京大学 |
非天然氨基酸标记的目的蛋白或肽的制备
|
EP3021942A4
(de)
|
2013-07-19 |
2017-04-19 |
The Regents of The University of California |
Epidermaler wachstumsfaktor 8 in form von milchfettkügelchen zur fettsäureaufnahmeregulierung
|
US9163284B2
(en)
|
2013-08-09 |
2015-10-20 |
President And Fellows Of Harvard College |
Methods for identifying a target site of a Cas9 nuclease
|
US9359599B2
(en)
|
2013-08-22 |
2016-06-07 |
President And Fellows Of Harvard College |
Engineered transcription activator-like effector (TALE) domains and uses thereof
|
US9322037B2
(en)
|
2013-09-06 |
2016-04-26 |
President And Fellows Of Harvard College |
Cas9-FokI fusion proteins and uses thereof
|
US9737604B2
(en)
|
2013-09-06 |
2017-08-22 |
President And Fellows Of Harvard College |
Use of cationic lipids to deliver CAS9
|
US9340800B2
(en)
|
2013-09-06 |
2016-05-17 |
President And Fellows Of Harvard College |
Extended DNA-sensing GRNAS
|
US11053481B2
(en)
|
2013-12-12 |
2021-07-06 |
President And Fellows Of Harvard College |
Fusions of Cas9 domains and nucleic acid-editing domains
|
EP3177718B1
(de)
|
2014-07-30 |
2022-03-16 |
President and Fellows of Harvard College |
Cas9-proteine mit ligandenabhängigen inteinen
|
KR102637699B1
(ko)
|
2014-10-24 |
2024-02-19 |
브리스톨-마이어스 스큅 컴퍼니 |
변형된 fgf-21 폴리펩티드 및 그의 용도
|
LT3456346T
(lt)
|
2015-07-30 |
2021-09-27 |
Macrogenics, Inc. |
Pd-1 ir lag-3 surišančios molekulės ir jų panaudojimo būdai
|
KR20180069898A
(ko)
|
2015-10-23 |
2018-06-25 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
핵염기 편집제 및 그의 용도
|
WO2017106061A1
(en)
|
2015-12-14 |
2017-06-22 |
Macrogenics, Inc. |
Bispecific molecules having immunoreactivity with pd-1 and ctla-4, and methods of use thereof
|
GB2568182A
(en)
|
2016-08-03 |
2019-05-08 |
Harvard College |
Adenosine nucleobase editors and uses thereof
|
AU2017308889B2
(en)
|
2016-08-09 |
2023-11-09 |
President And Fellows Of Harvard College |
Programmable Cas9-recombinase fusion proteins and uses thereof
|
US11542509B2
(en)
|
2016-08-24 |
2023-01-03 |
President And Fellows Of Harvard College |
Incorporation of unnatural amino acids into proteins using base editing
|
AU2017342543B2
(en)
|
2016-10-14 |
2024-06-27 |
President And Fellows Of Harvard College |
AAV delivery of nucleobase editors
|
WO2018087727A1
(en)
|
2016-11-14 |
2018-05-17 |
Novartis Ag |
Methods and compositions for treatment of cartilage damage and arthritis
|
WO2018119359A1
(en)
|
2016-12-23 |
2018-06-28 |
President And Fellows Of Harvard College |
Editing of ccr5 receptor gene to protect against hiv infection
|
EP3580232B1
(de)
|
2017-02-08 |
2023-09-20 |
Bristol-Myers Squibb Company |
Modifizierte relaxin-polypeptide mit einem pharmakokinetischen verstärker und deren verwendungen
|
EP3592853A1
(de)
|
2017-03-09 |
2020-01-15 |
President and Fellows of Harvard College |
Unterdrückung von schmerzen durch geneditierung
|
JP2020510439A
(ja)
|
2017-03-10 |
2020-04-09 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
シトシンからグアニンへの塩基編集因子
|
GB2575930A
(en)
|
2017-03-23 |
2020-01-29 |
Harvard College |
Nucleobase editors comprising nucleic acid programmable DNA binding proteins
|
JP2020517638A
(ja)
|
2017-04-20 |
2020-06-18 |
エータイアー ファーマ, インコーポレイテッド |
肺の炎症を治療するための組成物および方法
|
US11560566B2
(en)
|
2017-05-12 |
2023-01-24 |
President And Fellows Of Harvard College |
Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
|
CN111801345A
(zh)
|
2017-07-28 |
2020-10-20 |
哈佛大学的校长及成员们 |
使用噬菌体辅助连续进化(pace)的进化碱基编辑器的方法和组合物
|
US11319532B2
(en)
|
2017-08-30 |
2022-05-03 |
President And Fellows Of Harvard College |
High efficiency base editors comprising Gam
|
CN111757937A
(zh)
|
2017-10-16 |
2020-10-09 |
布罗德研究所股份有限公司 |
腺苷碱基编辑器的用途
|
LU100734B1
(en)
|
2018-03-15 |
2019-10-01 |
Univ Hamburg |
Synthetic transfer RNA with extended anticodon loop
|
US11434485B2
(en)
|
2018-03-15 |
2022-09-06 |
Arcturus Therapeutics, Inc. |
Synthetic transfer RNA with extended anticodon loop
|
CN112236622A
(zh)
|
2018-03-27 |
2021-01-15 |
艾斯彼控股,耐催德点火器有限公司的商定名称 |
用于灶具的热表面点火器
|
SG11202010439VA
(en)
|
2018-05-01 |
2020-11-27 |
Ambrx Inc |
A method for optimizing antibody expression
|
EP4389145A2
(de)
|
2018-09-11 |
2024-06-26 |
Ambrx, Inc. |
Interleukin-2-polypeptidkonjugate und deren verwendungen
|
JP2022512746A
(ja)
|
2018-10-19 |
2022-02-07 |
アンブルックス,インコーポレイテッド |
インターロイキン-10ポリペプチド複合体、その二量体、およびそれらの使用
|
CN111718920B
(zh)
*
|
2019-03-19 |
2021-05-07 |
宁波鲲鹏生物科技有限公司 |
在蛋白中高效引入赖氨酸衍生物的氨酰基-tRNA合成酶
|
CN113891936A
(zh)
|
2019-03-19 |
2022-01-04 |
布罗德研究所股份有限公司 |
编辑核苷酸序列的方法和组合物
|
LU101182B1
(en)
*
|
2019-04-11 |
2020-10-12 |
Univ Hamburg |
Synthetic transfer RNA with extended anticodon loop
|
JP2022528696A
(ja)
|
2019-04-11 |
2022-06-15 |
アークタラス テラピュウティクス、インク |
アンチコドンループを延長した合成転移rna
|
CN110172467B
(zh)
*
|
2019-05-24 |
2021-03-16 |
浙江大学 |
一种利用嵌合设计方法构建正交的氨酰-tRNA合成酶/tRNA体系
|
IL296099A
(en)
|
2020-03-11 |
2022-11-01 |
Ambrx Inc |
Interleukin-2 polypeptide conjugates and methods of using them
|
CA3177481A1
(en)
|
2020-05-08 |
2021-11-11 |
David R. Liu |
Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence
|
CN114250243B
(zh)
*
|
2020-09-24 |
2024-05-03 |
深圳华大生命科学研究院 |
一种检测极端嗜盐生物中氨酰-tRNA合成酶和tRNA活性的系统及方法
|
US20230201365A1
(en)
|
2021-07-09 |
2023-06-29 |
Bright Peak Therapeutics Ag |
Modified cd20 antibodies and uses thereof
|
WO2023281484A1
(en)
|
2021-07-09 |
2023-01-12 |
Bright Peak Therapeutics Ag |
Synthetic il-7 and il-7 immunocytokines
|
US20230201364A1
(en)
|
2021-07-09 |
2023-06-29 |
Bright Peak Therapeutics Ag |
Antibody conjugates and manufacture thereof
|
WO2023281483A1
(en)
|
2021-07-09 |
2023-01-12 |
Bright Peak Therapeutics Ag |
Modified tnf-antibodies and uses thereof
|
CN117615792A
(zh)
|
2021-07-09 |
2024-02-27 |
明峰治疗股份公司 |
检查点抑制剂与il-2的缀合物及其用途
|
WO2023069816A2
(en)
|
2021-09-20 |
2023-04-27 |
The Broad Institute, Inc. |
Compositions and methods for multiplex decoding of quadruplet codons
|
WO2023161854A1
(en)
|
2022-02-23 |
2023-08-31 |
Bright Peak Therapeutics Ag |
Immune antigen specific il-18 immunocytokines and uses thereof
|
US20240132563A1
(en)
|
2022-02-23 |
2024-04-25 |
Bright Peak Therapeutics Ag |
Bifunctional cytokine compositions
|
CN114908066B
(zh)
*
|
2022-05-17 |
2024-01-23 |
杭州嵌化合生医药科技有限公司 |
一种正交翻译系统及其在再分配密码子恢复ptc疾病中功能蛋白表达方面的应用
|
WO2024091824A1
(en)
|
2022-10-26 |
2024-05-02 |
Ada Forsyth Institute, Inc. |
Differentiation and reprogramming of chondrocyte
|
CN115975978B
(zh)
*
|
2023-02-01 |
2023-08-01 |
珠海宝锐生物科技有限公司 |
Bst DNA聚合酶大片段突变体及其应用
|